Translational research regarding the effect of TS-1 on CECs from metastatic or relapsed breast cancer patients.

Translational research regarding the effect of TS-1 on CECs from metastatic or relapsed breast cancer patients. - Translational research regarding the effect of TS-1 on CECs.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002793

Enrollment

Registered

2009-12-01

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic or relapsed breast cancer

Interventions

Internal use of TS-1

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)

Exclusion criteria

Exclusion criteria: 1)

Design outcomes

Primary

Measure	Time frame
To assess the changes of CECs or CEPs from the patients treated with TS-1.	—

Countries

Japan

Contacts

Public ContactWakako Tsuji

Kyoto University Hospital Breast Surgery Department

w-sato@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026